IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis
Europe - BIT:IVG - NL0015000LU4 - Common Stock
18.27 EUR
-0.02 (-0.11%)
We assign a fundamental rating of 5 out of 10 to IVG. IVG was compared to 105 industry peers in the Machinery industry. While IVG is still in line with the averages on profitability rating, there are concerns on its financial health. IVG is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
IVG had positive earnings in the past year.
IVG had a positive operating cash flow in the past year.
IVG had positive earnings in 4 of the past 5 years.
Each year in the past 5 years IVG had a positive operating cash flow.
1.2 Ratios
IVG has a Return On Assets (1.73%) which is comparable to the rest of the industry.
With a decent Return On Equity value of 12.39%, IVG is doing good in the industry, outperforming 76.19% of the companies in the same industry.
IVG's Return On Invested Capital of 4.53% is in line compared to the rest of the industry. IVG outperforms 45.71% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IVG is below the industry average of 8.78%.
The 3 year average ROIC (3.91%) for IVG is below the current ROIC(4.53%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 12.39% | ||
| ROIC | 4.53% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
1.3 Margins
IVG has a Profit Margin (2.17%) which is in line with its industry peers.
IVG's Profit Margin has improved in the last couple of years.
IVG has a Operating Margin of 5.00%. This is comparable to the rest of the industry: IVG outperforms 44.76% of its industry peers.
IVG's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 16.49%, IVG is not doing good in the industry: 87.62% of the companies in the same industry are doing better.
IVG's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5% | ||
| PM (TTM) | 2.17% | ||
| GM | 16.49% |
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IVG is destroying value.
IVG has less shares outstanding than it did 1 year ago.
IVG has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, IVG has an improved debt to assets ratio.
2.2 Solvency
IVG has an Altman-Z score of 1.76. This is a bad value and indicates that IVG is not financially healthy and even has some risk of bankruptcy.
IVG has a Altman-Z score (1.76) which is comparable to the rest of the industry.
The Debt to FCF ratio of IVG is 14.82, which is on the high side as it means it would take IVG, 14.82 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of IVG (14.82) is worse than 66.67% of its industry peers.
A Debt/Equity ratio of 1.35 is on the high side and indicates that IVG has dependencies on debt financing.
IVG's Debt to Equity ratio of 1.35 is on the low side compared to the rest of the industry. IVG is outperformed by 86.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | 14.82 | ||
| Altman-Z | 1.76 |
ROIC/WACC0.65
WACC6.97%
2.3 Liquidity
IVG has a Current Ratio of 1.98. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
IVG has a Current ratio of 1.98. This is in the better half of the industry: IVG outperforms 73.33% of its industry peers.
IVG has a Quick Ratio of 1.40. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.40, IVG is doing good in the industry, outperforming 77.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.4 |
3. Growth
3.1 Past
The earnings per share for IVG have decreased by -5.95% in the last year.
IVG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.82% yearly.
The Revenue has decreased by -6.97% in the past year.
The Revenue has been growing slightly by 5.06% on average over the past years.
EPS 1Y (TTM)-5.95%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-38.1%
Revenue 1Y (TTM)-6.97%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-3.52%
3.2 Future
IVG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.81% yearly.
Based on estimates for the next years, IVG will show a small growth in Revenue. The Revenue will grow by 3.92% on average per year.
EPS Next Y-10.65%
EPS Next 2Y7.14%
EPS Next 3Y9.67%
EPS Next 5Y10.81%
Revenue Next Year-2.83%
Revenue Next 2Y2.59%
Revenue Next 3Y3.46%
Revenue Next 5Y3.92%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 11.56 indicates a reasonable valuation of IVG.
Compared to the rest of the industry, the Price/Earnings ratio of IVG indicates a rather cheap valuation: IVG is cheaper than 81.90% of the companies listed in the same industry.
IVG's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.30.
With a Price/Forward Earnings ratio of 7.65, the valuation of IVG can be described as very cheap.
89.52% of the companies in the same industry are more expensive than IVG, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.73. IVG is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.56 | ||
| Fwd PE | 7.65 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IVG indicates a somewhat cheap valuation: IVG is cheaper than 79.05% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, IVG is valued a bit cheaper than the industry average as 69.52% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.39 | ||
| EV/EBITDA | 5.48 |
4.3 Compensation for Growth
IVG has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.35
EPS Next 2Y7.14%
EPS Next 3Y9.67%
5. Dividend
5.1 Amount
IVG has a Yearly Dividend Yield of 1.81%. Purely for dividend investing, there may be better candidates out there.
IVG's Dividend Yield is comparable with the industry average which is at 2.92.
Compared to the average S&P500 Dividend Yield of 2.45, IVG is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.81% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
27.33% of the earnings are spent on dividend by IVG. This is a low number and sustainable payout ratio.
DP27.33%
EPS Next 2Y7.14%
EPS Next 3Y9.67%
BIT:IVG (9/12/2025, 7:00:00 PM)
18.27
-0.02 (-0.11%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners41.97%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap4.96B
Analysts73.33
Price Target20.08 (9.91%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.81% |
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP27.33%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.8%
Min EPS beat(2)-15.44%
Max EPS beat(2)5.84%
EPS beat(4)3
Avg EPS beat(4)15.3%
Min EPS beat(4)-15.44%
Max EPS beat(4)63.53%
EPS beat(8)5
Avg EPS beat(8)15.63%
EPS beat(12)8
Avg EPS beat(12)16.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-10.1%
Max Revenue beat(2)8.56%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-10.1%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)0.74%
Revenue beat(12)7
Avg Revenue beat(12)2.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.76%
PT rev (3m)13.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.06%
EPS NY rev (1m)-7.23%
EPS NY rev (3m)-7.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.95%
Revenue NY rev (1m)-1.04%
Revenue NY rev (3m)-2.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.56 | ||
| Fwd PE | 7.65 | ||
| P/S | 0.33 | ||
| P/FCF | 12.39 | ||
| P/OCF | 3.84 | ||
| P/B | 1.91 | ||
| P/tB | 8.98 | ||
| EV/EBITDA | 5.48 |
EPS(TTM)1.58
EY8.65%
EPS(NY)2.39
Fwd EY13.07%
FCF(TTM)1.47
FCFY8.07%
OCF(TTM)4.75
OCFY26.01%
SpS54.61
BVpS9.58
TBVpS2.04
PEG (NY)N/A
PEG (5Y)0.35
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 12.39% | ||
| ROCE | 6% | ||
| ROIC | 4.53% | ||
| ROICexc | 5.79% | ||
| ROICexgc | 7.34% | ||
| OM | 5% | ||
| PM (TTM) | 2.17% | ||
| GM | 16.49% | ||
| FCFM | 2.7% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
ROICexc(3y)4.85%
ROICexc(5y)N/A
ROICexgc(3y)5.77%
ROICexgc(5y)N/A
ROCE(3y)5.17%
ROCE(5y)N/A
ROICexcg growth 3Y26.65%
ROICexcg growth 5Y12.05%
ROICexc growth 3Y25.45%
ROICexc growth 5Y11.07%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
F-Score6
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | 14.82 | ||
| Debt/EBITDA | 2.37 | ||
| Cap/Depr | 119.97% | ||
| Cap/Sales | 6% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 86.98% | ||
| Profit Quality | 124.22% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.4 | ||
| Altman-Z | 1.76 |
F-Score6
WACC6.97%
ROIC/WACC0.65
Cap/Depr(3y)146.94%
Cap/Depr(5y)121.88%
Cap/Sales(3y)5.9%
Cap/Sales(5y)5.2%
Profit Quality(3y)212.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.95%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-38.1%
EPS Next Y-10.65%
EPS Next 2Y7.14%
EPS Next 3Y9.67%
EPS Next 5Y10.81%
Revenue 1Y (TTM)-6.97%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-3.52%
Revenue Next Year-2.83%
Revenue Next 2Y2.59%
Revenue Next 3Y3.46%
Revenue Next 5Y3.92%
EBIT growth 1Y-21.25%
EBIT growth 3Y38.23%
EBIT growth 5Y15.55%
EBIT Next Year76.38%
EBIT Next 3Y30.18%
EBIT Next 5YN/A
FCF growth 1Y-7.83%
FCF growth 3YN/A
FCF growth 5Y-8.52%
OCF growth 1Y-0.31%
OCF growth 3Y26.42%
OCF growth 5Y8.96%